Drug Distribution Information for onchocerciasis control
2011

Mectizan Donation and Onchocerciasis Control

publication

Author Information

Author(s): Adrian Hopkins

Primary Institution: Mectizan Donation Program

Hypothesis

How much Mectizan® is needed for effective onchocerciasis control?

Conclusion

Regular treatment of at least 80% of the eligible population can lead to the elimination of onchocerciasis.

Supporting Evidence

  • Mectizan® has been donated for over twenty years for onchocerciasis control.
  • Treatment coverage of 80% can lead to the elimination of onchocerciasis.
  • Community distributors play a key role in collecting treatment data.

Takeaway

To help people with onchocerciasis, we need to give them a medicine called Mectizan®, and we have to make sure enough of it is available for everyone who needs it.

Methodology

Data on population and treatment coverage is collected by community distributors and health centre nurses, then centralized for analysis.

Potential Biases

Potential for incorrect data due to inadequate training or supervision of community distributors.

Limitations

Data collection can be slow and may not integrate well with existing health systems.

Participant Demographics

Community members eligible for treatment of onchocerciasis.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication